- Home
- SKT vs CAI Comparison
SKT vs CAI Comparison
Compare SKT & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKT | CAI |
|---|---|---|
| Founded | 1981 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.7B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | SKT | CAI |
|---|---|---|
| Price | $41.93 | $15.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $37.17 | $30.91 |
| AVG Volume (30 Days) | 749.7K | ★ 3.3M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.37 | $25.24 |
| Revenue Next Year | $3.90 | $22.32 |
| P/E Ratio | $171.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.24 | $14.19 |
| 52 Week High | $42.05 | $42.50 |
Technical Indicators
Market Signals| Indicator | SKT | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 63.80 | 37.05 |
| Support Level | $38.75 | $14.19 |
| Resistance Level | $42.05 | $19.83 |
| Average True Range (ATR) | 0.73 | 0.99 |
| MACD | 0.05 | -0.23 |
| Stochastic Oscillator | 90.86 | 8.94 |
Price Performance
Historical ComparisonAbout SKT Tanger Inc.
Tanger Inc is an owner and operator of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.